Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2019
At a glance
- Drugs Nepafenac (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Mati Therapeutics
- 14 Jan 2019 Status changed from recruiting to completed.
- 24 Sep 2018 Planned End Date changed from 1 Sep 2018 to 1 Dec 2018.
- 24 Sep 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History